Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fertility breakthrough? education on everyday chemicals may boost sperm count

NCT ID NCT07703046

Knowledge-focused Sponsor: Million Marker Wellness, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a behavioral education program can help men with low sperm quality reduce their exposure to endocrine disrupting chemicals (EDCs) found in everyday products. Participants complete 14 online modules over 8 weeks, and researchers measure changes in environmental health literacy, readiness to change habits, and sperm count. The goal is to see if knowledge alone can lead to healthier choices and better fertility.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a 14-module behavioral education program on endocrine disrupting chemicals and exposure reduction
What this could lead to
If successful, this program could help men reduce exposure to harmful chemicals and improve sperm quality, offering a simple, non-drug approach to male fertility.
What could go wrong
This is a small, early-stage study focused on feasibility and literacy changes, not clinical outcomes. The link between reduced exposures and improved sperm count is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men, * Reproductive Age, * Good Health, * Non-Smoker * English-Speaking * No Occupational/Medical Risks * not using steroids or TRT/hormone replacement supplements * low sperm count=total motile count below 20 million/ml * tested by Fellow in the last 3 months Exclusion Criteria: * Women * Non-Reproductive Age * Poor Health * Smoker * Non-English Speaking * Occupational/Medical Risks * using steroids or TRT/hormone replacement supplements * total motile count over 20 mil/ml, tested by Fellow over 3 months ago

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fertility are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder male infertility oligospermia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fertility Male fertility Sperm count, low Sperm quality

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Million Marker Wellness Inc.

    Berkeley, California, 94704, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.